Form D · Biotechnology
PROCLARA BIOSCIENCES, INC.
Cambridge, MA · CIK 0001423173
Offering snapshot reported Nov 16, 2018 · SEC filing
- Reported sold
- $6.92M Offering amount: $10M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 9, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2018 | Initial | $6,923,430 | No comparison | 10 | SEC filing |
| Nov 30, 2016 | Initial | $43,035,522 | No comparison | 50 | SEC filing |
| Apr 4, 2014 | Initial | $5,717,703 | No comparison | 54 | SEC filing |
| Mar 27, 2013 | Initial | $3,669,479 | No comparison | 31 | SEC filing |
| Mar 20, 2012 | Initial | $9,003,644 | No comparison | 31 | SEC filing |
| Mar 9, 2011 | Initial | $8,430,327 | No comparison | 32 | SEC filing |
| Jan 3, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-325993
Source: Form D, filed Nov 16, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kenneth Buckfire | Director |
| Valerie Calenda | Director |
| Valerie Calenda, Ph.D. | Director |
| John Dee | Director |
| Nico Dosenbach | Director |
| Richard Fischer, Ph.D. | Executive |
| Richard A. Fisher, Ph.D. | Director, Executive |
| Paul Goldenheim | Director |
| Paul Goldenheim, Md | Director |
| Franz Hefti, Ph.D. | Director |
| Hampus Hillerstrom | Executive |
| Nick Leschly | Director |
| Daniel Lynch | Director |
| David Michelson, M.D. | Director |
| Vicki Sato | Director |
| Hans Schoepflin | Director |
| Mark Skaletsky | Director |
| Peter Smedvig | Director |
| Jonathan Solomon | Director, Executive |
| Francois Valencony | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
85 Bolton St., Suite 212
Cambridge, MA, 02140
Cambridge, MA, 02140